Dysregulation of growth hormone in acquired generalized lipodystrophy.
Sahhar
Nael N
NN
National Center of Diabetes, Endocrinology and Genetics, Amman, Jordan.
Ahmad
Azmi T
AT
Ammari
Fawaz L
FL
Ajlouni
Kamel M
KM
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015248:Gemfibrozil / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000378:metabolism; D019382:Human Growth Hormone / Q000097:blood*; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology; D008060:Lipodystrophy / Q000097:blood* / Q000188:drug therapy; D008687:Metformin / Q000627:therapeutic use; D010901:Pituitary Function Tests
D001786:Blood Glucose; D015248:Gemfibrozil; D006442:Glycated Hemoglobin; D019382:Human Growth Hormone; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin